| Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets (NCT03420534) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2017-11-17 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL151 in Healthy Volunteers (NCT04557800) | Denali Therapeutics Inc. | 2017-11-16 |
| The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist (NCT03397888) | Portola Pharmaceuticals | 2017-11-16 |
| Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma (NCT03344367) | Peking University | 2017-11-16 |
| Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned (NCT03342859) | Bayer | 2017-11-16 |
| Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors (NCT03245151) | Eisai Inc. | 2017-11-16 |
| Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer (NCT03086642) | Karie D. Runcie, MD | 2017-11-16 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of CVU (NCT03257098) | RHEACELL GmbH & Co. KG | 2017-11-16 |
| Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants (NCT03362437) | Bristol-Myers Squibb | 2017-11-15 |
| Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM) (NCT03340883) | Chinook Therapeutics, Inc. | 2017-11-15 |
| Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta (NCT03064074) | Baylor College of Medicine | 2017-11-15 |
| Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome (NCT03047993) | M.D. Anderson Cancer Center | 2017-11-15 |
| Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers (NCT03195699) | Tvardi Therapeutics, Incorporated | 2017-11-15 |
| Intervention of Engineered Immune Effector T Cells Against Lung Cancer (NCT03353428) | Shenzhen Geno-Immune Medical Institute | 2017-11-15 |
| RBC Lifespan Measurement in Diabetic Children (NCT03073070) | Guohua An | 2017-11-15 |
| Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration (NCT03351400) | Sakakibara Heart Institute | 2017-11-15 |
| A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors (NCT03330106) | Millennium Pharmaceuticals, Inc. | 2017-11-15 |
| Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma (NCT03325101) | Mayo Clinic | 2017-11-15 |
| Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis (NCT03269409) | Mayo Clinic | 2017-11-15 |
| A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy (NCT03298516) | Genentech, Inc. | 2017-11-15 |
| A Study of Experimental Medication BMS-986235 in Healthy Subjects (NCT03335553) | Bristol-Myers Squibb | 2017-11-15 |
| ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer (NCT03480646) | Constellation Pharmaceuticals | 2017-11-15 |
| Evaluating MED2005 & Nitrostat Bioavailability (NCT04008732) | Futura Medical Developments Ltd. | 2017-11-15 |
| NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma (NCT02805894) | Nanobiotix | 2017-11-15 |
| Avelumab in G3 NEC (NCT03278405) | Sunnybrook Health Sciences Centre | 2017-11-15 |
| A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes (NCT03322631) | Eli Lilly and Company | 2017-11-15 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants (NCT03346122) | Janssen Research & Development, LLC | 2017-11-15 |
| A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer (NCT03356158) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2017-11-15 |
| Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects (NCT03472313) | Invicro | 2017-11-14 |
| Absorption & Elimination of Radiolabelled GSK2269557 (NCT03315559) | GlaxoSmithKline | 2017-11-14 |
| Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies (NCT03363893) | Carrick Therapeutics Limited | 2017-11-14 |
| A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study (NCT03382431) | Pulmocide Ltd | 2017-11-14 |
| A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System (NCT03397862) | Corium, Inc. | 2017-11-14 |
| A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer (NCT03706781) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2017-11-14 |
| Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside (NCT03383614) | Drugs for Neglected Diseases | 2017-11-14 |
| A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) (NCT03355794) | Children's Hospital Medical Center, Cincinnati | 2017-11-14 |
| ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects (NCT03361540) | Astellas Pharma Inc | 2017-11-14 |
| Study of Pembrolizumab (MK-3475) in Combination With Romidepsin (NCT03278782) | M.D. Anderson Cancer Center | 2017-11-14 |
| Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients (NCT03330990) | Hoffmann-La Roche | 2017-11-14 |
| Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder (NCT02990455) | Battelle Memorial Institute | 2017-11-14 |
| A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis (NCT03431610) | Novan, Inc. | 2017-11-13 |
| Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults (NCT03382405) | ModernaTX, Inc. | 2017-11-13 |
| Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101. (NCT03340220) | Xenon Pharmaceuticals Inc. | 2017-11-13 |
| QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas (NCT02582827) | NantBioScience, Inc. | 2017-11-13 |
| Combination Study of AZD5069 and Enzalutamide. (NCT03177187) | Institute of Cancer Research, United Kingdom | 2017-11-13 |
| A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM) (NCT03341312) | Eli Lilly and Company | 2017-11-13 |
| Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants (NCT03343626) | Takeda | 2017-11-13 |
| A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus (NCT03341299) | Eli Lilly and Company | 2017-11-13 |
| A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma (NCT03312530) | Hoffmann-La Roche | 2017-11-13 |
| Hyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer (LACC) Cervical Cancer (NCT03129776) | Sunnybrook Health Sciences Centre | 2017-11-13 |
| A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML) (NCT03125876) | Sunshine Lake Pharma Co., Ltd. | 2017-11-13 |
| A Study to Investigate the Effects of Imatinib on Pulmonary Vascular Dysfunction in a Human Model of Lung Injury (NCT03328117) | Exvastat Ltd. | 2017-11-13 |
| IACS-010759 in Advanced Cancers (NCT03291938) | M.D. Anderson Cancer Center | 2017-11-13 |
| A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (NCT03287908) | Amgen | 2017-11-13 |
| A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen (NCT03324685) | Biogen | 2017-11-11 |
| Safety, Tolerability and Pharmacokinetics Study of MK-7252 in Healthy Adult Participants (MK-7252-001) (NCT03326986) | Merck Sharp & Dohme LLC | 2017-11-10 |
| Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741 (NCT03376529) | Spero Therapeutics | 2017-11-10 |
| Estriol and Trimegestone Dose-response Trial With Single Dose Application of Vaginal Rings (NCT03343912) | Galeno Desenvolvimento de Pesquisas Clínicas | 2017-11-10 |
| A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus (NCT03339453) | Eli Lilly and Company | 2017-11-10 |
| A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer (NCT03344536) | Memorial Sloan Kettering Cancer Center | 2017-11-10 |
| Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care (NCT03456349) | Nxera Pharma UK Limited | 2017-11-10 |
| A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954 (NCT03277274) | Takeda | 2017-11-09 |
| A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants (NCT03341884) | Genentech, Inc. | 2017-11-09 |
| Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of CC-122 (NCT03340662) | Celgene | 2017-11-09 |
| Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC (NCT03181308) | Tracon Pharmaceuticals Inc. | 2017-11-09 |
| 28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men (NCT03298373) | Premier Research | 2017-11-09 |
| Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) (NCT03366064) | Asan Medical Center | 2017-11-09 |
| High Dose Rate Brachyablation of Primary Liver Lesions (NCT02893982) | University of Texas Southwestern Medical Center | 2017-11-09 |
| Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer (NCT03216343) | Chipscreen Biosciences, Ltd. | 2017-11-09 |
| A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet (NCT03362411) | Bristol-Myers Squibb | 2017-11-09 |
| A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM) (NCT03367390) | Eli Lilly and Company | 2017-11-08 |
| Omega-3 PUFA for Treatment of Patients With Idiopathic Oligoasthenoteratospermia (NCT03634644) | Jinling Hospital, China | 2017-11-08 |
| Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine (NCT03141138) | U.S. Army Medical Research and Development Command | 2017-11-08 |
| Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI (NCT03264456) | University of Alabama at Birmingham | 2017-11-08 |
| A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies (NCT03236857) | AbbVie | 2017-11-08 |
| Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer (NCT03294694) | Dana-Farber Cancer Institute | 2017-11-08 |
| Remote Limb Ischemic Conditioning to Enhance Learning and Muscle Strength in Healthy Young Adults (NCT03512028) | Washington University School of Medicine | 2017-11-08 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects (NCT03351751) | Pfizer | 2017-11-08 |
| Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03206047) | National Cancer Institute (NCI) | 2017-11-08 |
| Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects (NCT03376997) | Eisai Inc. | 2017-11-08 |
| Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. (NCT03345485) | Mundipharma Research Limited | 2017-11-08 |
| A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer (NCT03292172) | Hoffmann-La Roche | 2017-11-08 |
| SUNCIST: A Study of Calmangafodipir in Healthy Japanese and Caucasian Subjects (NCT03430999) | Egetis Therapeutics | 2017-11-07 |
| Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children (NCT03043391) | Istari Oncology, Inc. | 2017-11-07 |
| A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets (NCT03196531) | Xian-Janssen Pharmaceutical Ltd. | 2017-11-07 |
| A Study of Niclosamide in Patients With Resectable Colon Cancer (NCT02687009) | Michael Morse, MD | 2017-11-07 |
| A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors (NCT03355066) | Biosplice Therapeutics, Inc. | 2017-11-06 |
| High School SUCCESS: Vocational Soft Skills Program for Transition-Age ASD Youth (NCT04953793) | Rady Children's Hospital, San Diego | 2017-11-06 |
| Evaluation of IM Letrozole ISM® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1) (NCT03401320) | Rovi Pharmaceuticals Laboratories | 2017-11-06 |
| Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene (NCT03328130) | eyeDNA Therapeutics | 2017-11-06 |
| A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020) (NCT03230916) | Merck Sharp & Dohme LLC | 2017-11-06 |
| Pharmacokinetics of Progesterone in Pregnancy (NCT03340701) | Thomas Jefferson University | 2017-11-06 |
| A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males (NCT03335254) | TesoRx Pharma, LLC | 2017-11-06 |
| QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy (NCT03329248) | ImmunityBio, Inc. | 2017-11-06 |
| Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects (NCT04178070) | Genor Biopharma Co., Ltd. | 2017-11-06 |
| A Study to Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid Tumors (NCT03311477) | AbbVie | 2017-11-06 |
| Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy (NCT03333590) | Kevin Flanigan | 2017-11-06 |
| Clinical Pharmacology of FYU-981 (Final Formulation) (NCT03350373) | Mochida Pharmaceutical Company, Ltd. | 2017-11-06 |
| Bioavailability of ATI-1501 With Taste Test Sub Study (NCT03337126) | Appili Therapeutics Inc. | 2017-11-06 |
| Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia (NCT02770820) | Fred Hutchinson Cancer Center | 2017-11-06 |